Figure 3
Figure 3. Soluble LTα3 homotrimer is the important pathogenic lymphotoxin molecule in GVHD. (A) Survival by Kaplan-Meier analysis of lethally irradiated (1300 cGy) B6D2F1 mice transplanted with 5 × 106 BM and 2 × 106 CD3+ T cells from B6.WT, B6.Tnf−/− or B6.Lta−/− donors. Data are combined from 2 separate experiments (n = 16, BM + T groups; n = 6, TCD control group. P = .866, Tnf−/− vs Lta−/−; P < .009, Tnf−/− and Lta−/− vs WT). (B) Survival by Kaplan-Meier analysis of lethally irradiated B6D2F1 recipient mice that received BM + T grafts from B6.Lta−/−, B6.Ltb−/− or B6.WT donors. Data shown are combined from 2 separate experiments (n = 18, BM + T groups; n = 10, TCD control group, where TCD marrow was derived from B6 donors that were either B6.WT, B6.Lta−/− or B6.Ltb−/−). P = .018, Lta−/− vs WT; P < .0001 Ltb−/− vs WT. (C) Survival by Kaplan-Meier analysis of lethally irradiated BALB/c recipient mice transplanted with 5 × 106 BM and 0.5 × 106 CD3+ T cells from B6.Ltb−/−, B6.Lta−/− or B6.WT donors. Data shown are combined from 2 separate experiments (n = 12 in BM + T groups; n = 7 in TCD control group where the TCD donor was B6.Ltb−/−. P = .0011 Lta−/− vs WT; P = .212, Ltb−/− vs WT). (D) Survival by Kaplan-Meier analysis of BALB/c recipients of Lta−/− or WT grafts in which the T-cell dose was either 0.25 × 106 CD3+ per graft, or 106 CD3+ per graft. For 0.25 × 106 T cells: n = 10 per BM + T group; P = .0357 Lta−/− vs WT. For 106 T cells: n = 20 per BM + T group; P = .1657 Lta−/− vs WT. (E) Tissues from BALB/c recipient mice transplanted with 5 × 106 BM and 0.5 × 106 CD3+ T cells from B6.Lta−/− (n = 7), B6.WT donors (n = 8), or B6.WT TCD controls (n = 4) were taken 21 days after transplantation. Sections were prepared and scored for histopathology, including apoptosis, as described in “Histologic analysis.” For colon: P = .0016 Lta−/− vs WT; skin: P = .0088 Lta−/− vs WT. Representative photomicrographs (×250) from colon and skin 21 days after BMT. (F) Collated apoptosis scores from colon and skin, as described in “Histologic analysis,” P = .023, Lta−/− vs WT. Photomicrographs (×400) of TUNEL staining on representative colon, as described in “Histologic analysis.” (G) Survival by Kaplan-Meier analysis of lethally irradiated BALB/c recipient mice transplanted with 5 × 106 BM and 0.5 × 106 CD3+ T cells from B6.Tnf−/−, B6.Lta−/−, B6.Tnf/Lta−/−, or B6.WT donors. Data shown are combined from 2 separate experiments (n = 14 in BM + T groups; n = 10 in TCD control group; P ≤ .0007 for Tnf−/−, Lta−/− and Tnf/Lta−/− BM + T groups vs WT).

Soluble LTα3 homotrimer is the important pathogenic lymphotoxin molecule in GVHD. (A) Survival by Kaplan-Meier analysis of lethally irradiated (1300 cGy) B6D2F1 mice transplanted with 5 × 106 BM and 2 × 106 CD3+ T cells from B6.WT, B6.Tnf−/− or B6.Lta−/− donors. Data are combined from 2 separate experiments (n = 16, BM + T groups; n = 6, TCD control group. P = .866, Tnf−/− vs Lta−/−; P < .009, Tnf−/− and Lta−/− vs WT). (B) Survival by Kaplan-Meier analysis of lethally irradiated B6D2F1 recipient mice that received BM + T grafts from B6.Lta−/−, B6.Ltb−/− or B6.WT donors. Data shown are combined from 2 separate experiments (n = 18, BM + T groups; n = 10, TCD control group, where TCD marrow was derived from B6 donors that were either B6.WT, B6.Lta−/− or B6.Ltb−/−). P = .018, Lta−/− vs WT; P < .0001 Ltb−/− vs WT. (C) Survival by Kaplan-Meier analysis of lethally irradiated BALB/c recipient mice transplanted with 5 × 106 BM and 0.5 × 106 CD3+ T cells from B6.Ltb−/−, B6.Lta−/− or B6.WT donors. Data shown are combined from 2 separate experiments (n = 12 in BM + T groups; n = 7 in TCD control group where the TCD donor was B6.Ltb−/−. P = .0011 Lta−/− vs WT; P = .212, Ltb−/− vs WT). (D) Survival by Kaplan-Meier analysis of BALB/c recipients of Lta−/− or WT grafts in which the T-cell dose was either 0.25 × 106 CD3+ per graft, or 106 CD3+ per graft. For 0.25 × 106 T cells: n = 10 per BM + T group; P = .0357 Lta−/− vs WT. For 106 T cells: n = 20 per BM + T group; P = .1657 Lta−/− vs WT. (E) Tissues from BALB/c recipient mice transplanted with 5 × 106 BM and 0.5 × 106 CD3+ T cells from B6.Lta−/− (n = 7), B6.WT donors (n = 8), or B6.WT TCD controls (n = 4) were taken 21 days after transplantation. Sections were prepared and scored for histopathology, including apoptosis, as described in “Histologic analysis.” For colon: P = .0016 Lta−/− vs WT; skin: P = .0088 Lta−/− vs WT. Representative photomicrographs (×250) from colon and skin 21 days after BMT. (F) Collated apoptosis scores from colon and skin, as described in “Histologic analysis,” P = .023, Lta−/− vs WT. Photomicrographs (×400) of TUNEL staining on representative colon, as described in “Histologic analysis.” (G) Survival by Kaplan-Meier analysis of lethally irradiated BALB/c recipient mice transplanted with 5 × 106 BM and 0.5 × 106 CD3+ T cells from B6.Tnf−/−, B6.Lta−/−, B6.Tnf/Lta−/−, or B6.WT donors. Data shown are combined from 2 separate experiments (n = 14 in BM + T groups; n = 10 in TCD control group; P ≤ .0007 for Tnf−/−, Lta−/− and Tnf/Lta−/− BM + T groups vs WT).

Close Modal

or Create an Account

Close Modal
Close Modal